These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20647232)

  • 1. Prognostic significance of serum vascular endothelial growth factor per platelet count in unresectable advanced gastric cancer patients.
    Seo HY; Park JM; Park KH; Kim SJ; Oh SC; Kim BS; Kim YH; Kim JS
    Jpn J Clin Oncol; 2010 Dec; 40(12):1147-53. PubMed ID: 20647232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
    Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
    Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma.
    Mitsuhashi A; Suzuka K; Yamazawa K; Matsui H; Seki K; Sekiya S
    Cancer; 2005 Feb; 103(4):724-30. PubMed ID: 15637689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
    Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
    Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer.
    Vidal O; Metges JP; Elizalde I; Valentíni M; Volant A; Molina R; Castells A; Pera M
    Br J Surg; 2009 Dec; 96(12):1443-51. PubMed ID: 19918848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
    Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
    Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative serum vascular endothelial growth factor is not a marker for subsequent recurrence during long-term follow-up of colorectal cancer patients.
    Roumen RM; Slooter GD; Croiset van Uchelen FA; Huib LV
    Dis Colon Rectum; 2005 May; 48(5):1070-5. PubMed ID: 15785896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum vascular endothelial growth factor-C combined with multi-detector CT in the preoperative diagnosis of lymph node metastasis of gastric cancer.
    Wang TB; Wang J; Wei XQ; Wei B; Dong WG
    Asia Pac J Clin Oncol; 2012 Jun; 8(2):180-6. PubMed ID: 22524577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary results regarding vascular endothelial growth factor (VEGF-A) levels in the serum of gastric cancer patients].
    Hălmaciu I; Gurzu S; Dobreanu M; Suciu BA; Brînzaniuc K
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):446-51. PubMed ID: 23077935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential prognostic value of circulating levels of vascular endothelial growth factor-A in patients with gastric cancer.
    Ding S; Lin S; Dong X; Yang X; Qu H; Huang S; Liu W; Zhou L; Liu D
    In Vivo; 2005; 19(4):793-5. PubMed ID: 15999551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 tumor expression in patients with advanced laryngeal cancer after induction chemotherapy for organ preservation.
    Rueda A; Cazorla O; Pérez L; Álvarez M; Redondo M; Gallego E; Sáez M; Medina JA; Solano J; Matilla A
    Head Neck; 2011 Jun; 33(6):808-16. PubMed ID: 20967863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: a retrospective analysis.
    Sougioultzis S; Syrios J; Xynos ID; Bovaretos N; Kosmas C; Sarantonis J; Dokou A; Tzivras D; Zografos G; Felekouras E; Papalambros E; Tsavaris N
    Eur J Surg Oncol; 2011 Apr; 37(4):312-8. PubMed ID: 21300519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
    D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
    Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
    Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
    Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer.
    Szaflarska A; Szczepanik A; Siedlar M; Czupryna A; Sierzega M; Popiela T; Zembala M
    Anticancer Res; 2009 Dec; 29(12):5005-12. PubMed ID: 20044609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating stromal cell derived factor-1alpha (SDF-1alpha) is predictive of distant metastasis in gastric carcinoma.
    Woo IS; Hong SH; Byun JH; Kang JH; Jeon HM; Choi MG
    Cancer Invest; 2008; 26(3):256-61. PubMed ID: 18317966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients.
    Kikuchi S; Obata Y; Yagyu K; Lin Y; Nakajima T; Kobayashi O; Kikuichi M; Ushijima R; Kurosawa M; Ueda J
    Cancer Sci; 2011 Apr; 102(4):866-9. PubMed ID: 21219538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of gastric cancer patients with bone marrow metastases.
    Kim HS; Yi SY; Jun HJ; Lee J; Park JO; Park YS; Jang J; Kim HJ; Ko Y; Lim HY; Kang WK
    Oncology; 2007; 73(3-4):192-7. PubMed ID: 18418012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative serum vascular endothelial growth factor-a is a marker for subsequent recurrence in colorectal cancer patients.
    Alabi AA; Suppiah A; Madden LA; Monson JR; Greenman J
    Dis Colon Rectum; 2009 May; 52(5):993-9. PubMed ID: 19502868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.